Stock listing

Qiagen N.v.

Selected listing: A41HBE · LS · EUR · DE

Qiagen N.v. (Lang & Schwarz: A41HBE), Health Technology. Latest release Oct 6, 2026: QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery.

A41HBE:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41HBE
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Qiagen N.v.

QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery

October 6, 2026

QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

September 28, 2026

QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation

September 24, 2026

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board

September 18, 2026

QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction

August 27, 2026

All Qiagen N.v. news →

Events

Replays

Qiagen N.V. (QGEN) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 09:30 AM ET
Watch
Qiagen N.V. (QGEN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 09:30 AM ET
Watch
Qiagen N.V. (QGEN) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 09:30 AM ET
Watch

Research Qiagen N.v.

Qiagen N.v. company profile

View the public company page for Qiagen N.v. on 6ix.

Qiagen N.v. news

Read company news and market updates connected to Qiagen N.v..

Qiagen N.v. investor events

Find investor webinars, events, and replay context for Qiagen N.v..